Calgary Orthopaedic Research and Education FundOTHER
3 Previous Clinical Trials
376 Total Patients Enrolled
Neil White, MDPrincipal InvestigatorUniversity of Calgary
1 Previous Clinical Trials
550 Total Patients Enrolled
Age Any Age · All Participants · 3 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:
Subject has a scaphoid fracture that is more than three months old and has at least one feature of non-union, including a collapse or humpback deformity, sclerosis at the fracture site, or cystic changes evident on pre-operative diagnostic imaging.
The subject is willing and able to use the ultrasound device for four to six months after surgery.
The subject has agreed to allow the surgeon to fix the problem as they see fit.
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.